{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:cefotaxime-sodium-powder-for-solution",
  "slug": "cefotaxime-sodium-powder-for-solution",
  "title": "FDA shortage status: Cefotaxime Sodium Powder, for Solution",
  "ingredient": "Cefotaxime Sodium Powder, for Solution",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "CEFOTAXIME"
  ],
  "therapeutic_categories": [
    "Anti-Infective",
    "Pediatric"
  ],
  "dosage_forms": [
    "Powder, For Solution"
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "package_count": 6,
  "packages": [
    {
      "package_ndc": "0143-9931-25",
      "product_ndc": "0143-9930",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)",
      "availability": "Unavailable",
      "dosage_form": "Powder, For Solution",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/17/2015",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9935-01",
      "product_ndc": "0143-9935",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)",
      "availability": "Unavailable",
      "dosage_form": "Powder, For Solution",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/17/2015",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9933-25",
      "product_ndc": "0143-9930",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)",
      "availability": "Unavailable",
      "dosage_form": "Powder, For Solution",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/17/2015",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9930-10",
      "product_ndc": "0143-9930",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)",
      "availability": "Unavailable",
      "dosage_form": "Powder, For Solution",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/17/2015",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "21586-011-02",
      "product_ndc": "21586-011",
      "company_name": "SteriMax, Inc.",
      "manufacturer_name": "SteriMax Inc.",
      "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)",
      "availability": "Available",
      "dosage_form": "Powder, For Solution",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/15/2026",
      "initial_posting_date": "02/17/2015",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "21586-012-02",
      "product_ndc": "21586-011",
      "company_name": "SteriMax, Inc.",
      "manufacturer_name": "SteriMax Inc.",
      "presentation": "Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)",
      "availability": "Available",
      "dosage_form": "Powder, For Solution",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/15/2026",
      "initial_posting_date": "02/17/2015",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 2,
    "Unavailable": 4
  },
  "initial_posting_date": "02/17/2015",
  "latest_source_update": "08/13/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}